References
- Kontaxakis VP, Havaki-Kontaxaki BJ, Ferentinos PP, Paplos KG, Soldatos CR. Switching to amisulpride monotherapy for treatment-resistant schizophrenia. Eur Psychiatry 2006; 21: 214–217
- McKeage K, Plosker GL. Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs 2004; 18: 933–956
- Möller HJ. Amisulpride: Limbic specificity and the mechanism of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1101–1111
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther 1981; 30(2)239–245
- Seki S, Igawa Y, Kaidoh K, Ishizuka O, Nishizawa O, Anderson KE. Role of Dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol Urody 2001; 20(1)105–113
- Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9(3)207–209